ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,912.98
      3.23%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Dare Bioscience Inc (DARE)

      7. Dare Bioscience Inc (DARE) Financials

      Dare Bioscience Inc

      Dare Bioscience Inc (DARE)

      NASDAQ
      3.63
      0.03
      (0.83%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      3.63
      0.00
      ( 0.00% )
      After Hours: 6:49PM
      Delayed by 15 minutes

      Dare Bioscience Inc Financial Summary

      The current DARE market cap is 30.58M. The company's latest EPS is USD -3.5802 and P/E is -1.01.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 001M1.81M9k
      Operating Income -8.38M-8.99M-8.4M-5.17M-6.02M
      Net Income -8.04M-8.76M-8.3M-5.06M-6.76M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00010M2.81M
      Operating Income -14.34M-27.4M-39.07M-31.39M-30.94M
      Net Income -15.05M-27.4M-38.7M-30.95M-30.16M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 30.37M23.21M25.05M21.28M13.01M
      Total Liabilities 25.4M25.93M27.34M26.33M24.01M
      Total Equity 4.97M-2.72M-2.29M-5.05M-11M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 7.44M7.55M55.81M43.83M21.28M
      Total Liabilities 7M8.7M17.05M32.71M26.33M
      Total Equity 441k-1.15M38.75M11.11M-5.05M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -16.12M-22.7M-30.68M-38.86M-6.81M
      Investing N/A N/A -22k-629k-7k
      Financing 1.3M1.75M10.33M15.64M14k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -13.32M-25.24M-28.76M-18.09M-38.86M
      Investing 6.14M-18k-15k-63k-629k
      Financing 5.15M25.13M75.85M1.34M15.64M

      Stats and Ratios

      Market Cap 30.58M
      Price to Earnings Ratio -1.01
      Price to Sales Ratio 10.8
      Price to Cash Ratio 2.9
      Price to Book Ratio -6.01
      Dividend Yield -

      Share Statistics

      Shares Outstanding 8.42M
      Average Volume (1 week) 46.36k
      Average Volume (1 Month) 55.41k
      52 Week Change -59.89%
      52 Week High 9.474
      52 Week Low 3.05
      Spread (Intraday) 0.48 (12.06%)

      Company Info

      Company Name Dare Bioscience Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.darebioscience.com
      Industry pharmaceutical preparations (2834)